In terms of valuation, Mira Pharmaceuticals Inc’s market capitalization stands at $15.52 million. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s ...

"We are fully committed to bringing this breakthrough drug to patients as quickly as possible while backing everything we do ...

The firm says it could offer an alternative to existing treatments while sidestepping addiction concerns that have plagued ...

After hours: October 18 at 7:39 PM EDT Loading Chart for MIRA ...

MIRA Pharmaceuticals (MIRA) announced that its novel oral ketamine analog, Ketamir-2, has shown greater pain relief compared to FDA-approved ...

MIRA READ THE FULL MIRA RESEARCH REPORT MIRA Pharmaceuticals (NASDAQ:MIRA) is a preclinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Fintel reports that on September 30, 2024, Rodman & Renshaw initiated coverage of MIRA Pharmaceuticals (NasdaqCM:MIRA) with a ...